Dark Days For Sun As Governance Saga Escalates
Executive Summary
Allegations of corporate governance lapses continued to singe Sun, but there is little clarity on which way things are headed, at least for now.
You may also be interested in...
Concerns Over Alleged Lapses By Sun Fading?
Early indications that a whistleblower’s allegations of certain serious irregularities by Sun Pharma may not hold water lifted its shares, though it remains unclear if the issue stands completely closed.
Sun Firefights Governance Concerns
Sun has promised to implement certain changes to address corporate governance concerns that have riled investors, including “unwinding” a loan transaction and doing away with a controversial related party arrangement for domestic sales. But will that be enough for markets to "forget" allegations of lapses or "re-rate" the firm any time soon?
India Corporate Governance Practices – Will Pharma Walk The Gandhian Path?
As Sun Pharma firefights allegations of corporate governance lapses, Scrip speaks to multiple experts on how they view the governance landscape across Pharma Inc in India and also some key sticking points.